Clinical Neuroproteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.
Proteored-ISCIII. Proteomics Platform, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Irunlarrea 3, 31008 Pamplona, Spain.
Int J Mol Sci. 2020 Sep 2;21(17):6371. doi: 10.3390/ijms21176371.
Olfactory dysfunction is one of the prodromal symptoms in dementia with Lewy bodies (DLB). However, the molecular pathogenesis associated with decreased smell function remains largely undeciphered. We generated quantitative proteome maps to detect molecular alterations in olfactory bulbs (OB) derived from DLB subjects compared to neurologically intact controls. A total of 3214 olfactory proteins were quantified, and 99 proteins showed significant alterations in DLB cases. Protein interaction networks disrupted in DLB indicated an imbalance in translation and the synaptic vesicle cycle. These alterations were accompanied by alterations in AKT/MAPK/SEK1/p38 MAPK signaling pathways that showed a distinct expression profile across the OB-olfactory tract (OT) axis. Taken together, our data partially reflect the missing links in the biochemical understanding of olfactory dysfunction in DLB.
嗅觉功能障碍是路易体痴呆(DLB)的前驱症状之一。然而,与嗅觉功能下降相关的分子发病机制在很大程度上仍未被破译。我们生成了定量蛋白质组图谱,以检测来自 DLB 患者与神经功能正常对照者的嗅球(OB)中的分子变化。共定量了 3214 种嗅觉蛋白,99 种蛋白在 DLB 病例中发生了显著变化。DLB 中破坏的蛋白质相互作用网络表明翻译和突触小泡循环失衡。这些变化伴随着 AKT/MAPK/SEK1/p38 MAPK 信号通路的改变,该通路在 OB-嗅觉径(OT)轴上表现出不同的表达谱。总之,我们的数据部分反映了在 DLB 中嗅觉功能障碍的生化理解中缺失的环节。